EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Treatment of gingival recession type 1 using coronally advanced flap with leucocytes-platelet rich fibrin: a randomized controlled trial

Nuno Bernardo Malta Dos Santos, Gustavo Vicentis Oliveira Fernandes, Tiago Marques, Manuel Correia Sousa, André Correia, María Pilar Batalla Vázquez, Juan Blanco-Carrión

Clinical Oral Investigations · 2026

DOI: 10.1007/s00784-026-06899-4 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Oral Investigations, 2026. Verfasst von Nuno Bernardo Malta Dos Santos und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Dental Medicine, Universidade Católica Portuguesa, Viseu, 3504-505, Portugal. Hauptthemen laut MEDLINE: Gingival Recession, Platelet-Rich Fibrin, Gingiva. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: A.T. Still University, Mesa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to evaluate the clinical outcomes of gingival recession Type 1 (RT1) treatment using a coronally advanced flap (CAF) alone and in combination with L-PRF at 6 months. Materials and methods A total of 70 RT1 from 19 patients were included. Participants were randomly assigned to the test group (TG, CAF + L-PRF, n = 42) and the control group (CG) (CAF alone, n = 28). Clinical parameters were assessed at baseline and at 6 months: the primary outcomes were percentage of root coverage (%RC) and complete root coverage (CRC); and the secondary outcomes included mean root coverage (MRC), changes in gingival thickness (GT) and volumetric tissue gain, recession area reduction, analgesic consumption, healing quality (the Inflammatory Proliferative Remodeling [IPR] score), and patient-reported outcome measures (PROMs). Statistical analyses were performed to determine differences between groups; a random-intercept mixed-effects model was used for all site-level outcomes.

Results

At six months, %RC was 89.30% ± 20.33% (TG) and 81.60% ± 27.93% (CG) ( p > 0.05). For the TG and CG, respectively, %CRC was 73.81% and 57.14%; the mean GT gain was 0.16 ± 0.10 mm and 0.11 ± 0.10 mm ( p = 0.08); the mean volume gain was 1.13 ± 1.25 mm 3 and 0.86 ± 0.84 mm 3 ( p = 0.32); the mean number of pills taken was 1.67 ± 0.98 and 2.25 ± 1.02 ( p = 0.04); the esthetic satisfaction was 95% ± 5% and 90% ± 7% ( p = 0.31); willingness to undergo the procedure again: 93% ± 4% and 88% ± 6% ( p = 0.22); sensitivity reduction: 85% ± 6% and 80% ± 8% ( p = 0.19). There was no statistically significant difference in healing quality and PROMs.

Conclusion

Both CAF alone and CAF combined with L-PRF yielded comparable clinical and volumetric outcomes in RT1 treatments. No statistically significant advantages were observed with the adjunctive use of L-PRF. Clinical relevance Because CAF alone achieves high predictability for RT1 defects, the routine adjunctive use of L-PRF provides limited additional clinical benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gingival RecessionPlatelet-Rich FibrinGingivaHumansPatient Reported Outcome MeasuresMaleFemaleYoung AdultAdultSurgical FlapsWound Healing

Stichwörter der Autor:innen

Digital assessmentGingival recessionPeriodontal plastic surgeryPlatelet-Rich FibrinRoot coverage

Autor:innen und Institutionen

  • Faculty of Dental Medicine, Universidade Católica Portuguesa, Viseu, 3504-505, Portugal.
  • University of Santiago de Compostela, Santiago de Compostela, Spain.
  • Center for Interdisciplinary Research in Health, Universidade Católica Portuguesa, Viseu, 3504-505, Portugal. gustfernandes@gmail.com.
  • A. T. Still University - Missouri School of Dentistry & Oral Health, 1500 Park Av., St. Louis, MO, 63104, USA. gustfernandes@gmail.com.
  • Center for Interdisciplinary Research in Health, Universidade Católica Portuguesa, Viseu, 3504-505, Portugal.
  • Periodontology Unit, School of Medicine and Dentistry, University of Santiago de Compostela, Praza do Obradoiro, s/n, Santiago de Compostela, 15782, Spain.

Förderung

  • A.T. Still University, Mesa

Zitieren

APA

Dos Santos, N. B. M., Fernandes, G. V. O., Marques, T., Sousa, M. C., Correia, A., Vázquez, M. P. B., & Blanco-Carrión, J. (2026). Treatment of gingival recession type 1 using coronally advanced flap with leucocytes-platelet rich fibrin: a randomized controlled trial. Clinical Oral Investigations. https://doi.org/10.1007/s00784-026-06899-4

Vancouver

Dos Santos NBM, Fernandes GVO, Marques T, Sousa MC, Correia A, Vázquez MPB, et al. Treatment of gingival recession type 1 using coronally advanced flap with leucocytes-platelet rich fibrin: a randomized controlled trial. Clinical Oral Investigations. 2026. doi:10.1007/s00784-026-06899-4

BibTeX
@article{DosSantos2026,
  author = {Dos Santos, Nuno Bernardo Malta and Fernandes, Gustavo Vicentis Oliveira and Marques, Tiago and Sousa, Manuel Correia and Correia, André and Vázquez, María Pilar Batalla and Blanco-Carrión, Juan},
  title = {Treatment of gingival recession type 1 using coronally advanced flap with leucocytes-platelet rich fibrin: a randomized controlled trial},
  journal = {Clinical Oral Investigations},
  year = {2026},
  doi = {10.1007/s00784-026-06899-4}
}
Kostenlos starten →